Search
InsiderInsights.com

Weiss Michael S (1038977)

Weiss Michael S has been a registered insider at 3 firms since 2002. As a Director at FABIEN CORP, Weiss Michael S last made a transaction on 11/14/2023. As Chief Executive Officer at MANHATTAN PHARMA INC, Weiss Michael S last made a transaction on 8/11/2023. As a Beneficial Owner of 5% or more of a class of the company's shares at Keryx Biopharmaceuticals, Inc., Weiss Michael S last made a transaction on 5/10/2010.

CORONADO BIOSCIENCES INC (FBIO, CNDO)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 50% 88% -- 176 1 Year 2 0% -- -- --
2 100% 63% 63% 61 9 Month 2 0% -- -- --
2 50% -1% -1% 47 6 Month 2 0% -- -- --
2 50% 14% 14% 34 3 Month 2 0% -- -- --
2 100% 62% 62% 106 1 Month 2 0% -- -- --
2 100% 27% 27% 54 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 12/11/2024 07:35 AM EST Latest Transaction Date: 11/14/2023
Average days between Transaction and Entered Dates: 3

TG THERAPEUTICS, INC. (MHAN, TGTXD, TGTX)

Titles: CEO,PR,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
3 100% 21% 131% 650 1 Year 3 0% -102% -- 255
3 100% -50% 56% 424 9 Month 3 0% -102% -- 255
4 75% -8% 38% 394 6 Month 4 0% -51% -- 255
5 20% 13% -5% 137 3 Month 5 0% -0% -- 1
5 20% -1% -5% 24 1 Month 5 0% -0% -- 1
5 20% 0% -2% 19 1 Week 5 0% -0% -- 1
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 100% -33% -33% 11 1 Year 2 0% -- -- --
2 100% -38% -38% 59 9 Month 2 0% -- -- --
2 50% -30% -30% 76 6 Month 2 0% -- -- --
2 50% -14% -14% 67 3 Month 2 0% -- -- --
2 100% -28% -28% 28 1 Month 2 0% -- -- --
2 50% -4% -4% 13 1 Week 2 0% -- -- --
Scorecards Updated 12/11/2024 07:35 AM EST Latest Transaction Date: 8/11/2023
Average days between Transaction and Entered Dates: 2

KERYX BIOPHARMACEUTICALS INC (KERX)

Titles: BO

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
3 100% 145% 191% 237 1 Year 3 0% -- -- --
3 100% 39% 5% 109 9 Month 3 0% -- -- --
3 67% 56% 7% 290 6 Month 3 0% -- -- --
3 67% 53% 0% 290 3 Month 3 0% -- -- --
3 33% -11% -19% 26 1 Month 3 0% -- -- --
3 100% 13% 8% 20 1 Week 3 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
15 87% -24% -27% 46 1 Year 15 0% -- -- --
15 100% -23% -26% 25 9 Month 15 0% -- -- --
15 73% -13% -15% 42 6 Month 15 0% -- -- --
15 87% -22% -26% 54 3 Month 15 0% -- -- --
15 73% -9% -8% 52 1 Month 15 0% -- -- --
15 67% -5% -4% 27 1 Week 15 0% -- -- --
Scorecards Updated 12/11/2024 07:35 AM EST Latest Transaction Date: 5/10/2010
Average days between Transaction and Entered Dates: 3
© 2024 InsiderInsights.com